BioNanoMedicine in Combating Cancer
Oslo Cancer Cluster invites you to the symposium “BioNanoMedicine in Combating Cancer”. Advances in nanotechnology and nanomedicine have significantly influenced diagnostic and therapeutic options in oncology and the whole health industry is undergoing substantial changes. This symposium will focus on the recent developments, difficulties and breakthroughs as well as emerging and future trends of the converging fields of nanotechnology, biotechnology and medicine.
This symposium includes a networking session focusing on Horizon 2020 funding opportunities for both academia and industry in the fields of oncology, personalised medicine and nanotechnology. The networking session also offers to the participants the opportunity to discuss new collaborative projects.
This symposium is supported by
For sponsorship opportunities and other queries, connect to cwh@oslocancercluster.no (or) gu@oslocancercluster.no
Registration
There is no cost attend this event. Please register by completing the form at the end of this page.
Draft Agenda
Moderator of the day: Gupta Udatha (Oslo Cancer Cluster)
10:00–10:15 | REGISTRATION & COFFEE |
10:15–10:20 | Welcome and Introduction
Gupta Udatha, Oslo Cancer Cluster, Norway |
10:20–10:50 | Smart Cancer Nanomedicine
Prof. Twan Lammers, RWTH Aachen University, Germany |
10:50–11:20 | Nanoparticles for Clinical Use: Importance of Degradation and Excretion
Dr. Tore Skotland, The Norwegian Radium Hospital, Norway |
11:20–11:50 | Targeted and Nano Therapies in Ovarian Cancer
Dr. Flavio Rizzolio, Ca’ Foscari University of Venice, Italy |
11:50–12:30 | LUNCH BREAK |
12:30–13:00 | Why Specialized Characterization is Crucial – Nanomedicines Towards the Clinic
Dr. Ruth Schmid-Baumberger, SINTEF, Norway |
13:00–13:30 | Ultrasound-Mediated Delivery of Nanoparticles to Tumors
Prof. Catharina de Lange Davies, Norwegian University of Science and Technology, Norway |
13:30–14:00 | H-Ferritin: A Theranostic Bionanoplatform for Advanced Imaging and Therapy of Solid Tumors
Prof. Davide Prosperi, NanoBioLab, University of Milano Bicocca, Italy |
14:00–14:20 | COFFEE BREAK |
14:20–14:50
|
Developing an Innovative Strategy for the Synthesis of Colloidally Stable Nanoconjugates for Cancer Targeting
Dr. Rany Rotem, Marie Curie ITN Fellow, University of Milano Bicocca, Italy |
14:50–15:20 | Horizon 2020 – Upcoming Calls & Funding Opportunities
Dr. Cecilie Anita Mathiesen & NCPs, The Research Council of Norway, Norway |
15:20–16:00 | SUMMARY & NETWORKING
Dr. Gupta Udatha, Oslo Cancer Cluster, Norway |